Urgent recall of cholesterol drug with 'serious health consequences' warning
Golden State Medical Supply Inc. has issued a voluntary recall for nearly 3,000 bottles of Niacin Extended-Release tablets due to failed dissolution testing. The FDA has classified this as a Class II risk, meaning the medication may release less active ingredient than intended.
Why it matters
Patients relying on cholesterol medication may not be receiving the correct dosage, potentially impacting their long-term cardiovascular health.
The US Food and Drug Administration (FDA) on Friday issued a report that 2,961 bottles of a 1,000-milligram Vitamin B supplement used to lower high cholesterol and triglycerides had been recalled.
The article reports factual information regarding an FDA recall without emotive language or political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in